The International Biotechnology Industry: A Dynamic Capabilities Perspective
By Anoop Madhok, T. Osegowitsch. 2000
139 citations recorded by the source corpus.
View Paper: https://www.semanticscholar.org/paper/d711f4418a325f420a42f424858953ca5a6895f8
How researchers see this paper
The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.
- Yin-Xuan Lin
- Vivid C. Lee
- Peter J. Sher
- Lei-Yu Wu
- Mark Easterby-Smith
- Magnus Klofsten
- Jaffar Abbas
- Richard J. Arend
Citations in the corpus
- Reassessing the fundamentals and beyond: Ronald Coase, the transaction cost and resource-based theories of the firm and the institutional structure of production (2002, background): “Yet, they could also be approached as complements, especially in situations involving learning (Cohen and Levinthal, 1990; Madhok and Osegowitsch, 2000).”
- Dynamic Capabilities: A Review and Research Agenda (2007, unknown): “…possession, deployment and upgrading in international expansion (Luo 2000), technology accumulation in cross-border transactions of biotech firms (Madhok and Osegowitsch 2000), continuous transformation of organizational forms in Yahoo! and Excite (Rindova and Kotha 2001), mobilizing and…”
- Information technology as a facilitator for enhancing dynamic capabilities through knowledge management (2004, background): “Likewise, good management of the integrative learning mechanisms of endogenous knowledge promotes dynamic capabilities and thus builds competitive advantage [17,33].”
- Exploring the role of dynamic capabilities in firm performance under the resource-based view framework (2014, background): “Finally, Section 5 summarizes conclusions, discussions, limitations and future research directions.”